Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:40

Hormonal Regulation

37.7K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
37.7K
Hormonal Regulation01:33

Hormonal Regulation

30.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.5K
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

46.0K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
46.0K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

3.9K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.9K
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

6.5K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
6.5K
Hormones of the Pituitary Gland01:27

Hormones of the Pituitary Gland

14.2K
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
14.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menopausal hormone therapy and pulmonary diseases.

Climacteric : the journal of the International Menopause Society·2026
Same author

Evaluation of breast risk at menopause: what impact on the use of menopausal hormone therapy?

Maturitas·2026
Same author

Evidence for actions of estrone distinct from those of estradiol.

The Journal of clinical endocrinology and metabolism·2026
Same author

Letter to the editor about the article "relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis".

Annals of medicine·2026
Same author

Menopausal hormone treatment and breast cancer.

The lancet. Diabetes & endocrinology·2026
Same author

French protocol for the diagnosis and management of hereditary angioedema.

La Revue de medecine interne·2025

Related Experiment Video

Updated: May 6, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K

[Still a place for hormone replacement therapy?].

Anne Gompel1

  • 1Université Paris-Descartes, Port Royal-Cochin, unité de gynécologie médicale, 75014 Paris, France.

Presse Medicale (Paris, France : 1983)
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Hormone replacement therapy (HRT) is effective for menopausal symptoms, with benefits potentially outweighing risks for women aged 50-60. French HRT regimens show reduced risks for thrombosis, stroke, and breast cancer, and decrease type 2 diabetes risk.

More Related Videos

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Related Experiment Videos

Last Updated: May 6, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Area of Science:

  • Reproductive Endocrinology
  • Menopause Management
  • Pharmacology

Context:

  • The Women's Health Initiative (WHI) study led to a significant decline in hormone replacement therapy (HRT) prescriptions.
  • Current clinical guidelines often reflect a cautious approach to HRT due to past study findings.
  • There is a need to re-evaluate the risk-benefit profile of HRT, particularly in specific patient populations.

Purpose:

  • To reassess the efficacy and safety of hormone replacement therapy (HRT) for managing climacteric symptoms.
  • To evaluate the specific risks and benefits associated with different HRT regimens, including the French approach.
  • To determine the applicability of large-scale trial results to younger postmenopausal women.

Summary:

  • HRT is the most effective treatment for menopausal symptoms, and the decline in its use post-WHI may be unjustified.
  • Benefits, such as decreased type 2 diabetes risk, may outweigh harms in women aged 50-60.
  • The French HRT approach demonstrates no increased risk of thrombosis or stroke, and a lower breast cancer risk compared to other regimens.

Impact:

  • Findings suggest that HRT, particularly specific regimens, could be more widely considered for symptom management in appropriate age groups.
  • Re-evaluation of HRT guidelines may be warranted, considering the potential benefits for conditions like type 2 diabetes.
  • Individualized risk-benefit assessments are crucial, as results from large trials may not be directly generalizable to all postmenopausal women.